Cynthia Koons
-
Merck Is In Advanced Talks To Buy Cancer Drugmaker Harpoon Therapeutics
Merck is discussing paying roughly $23 a share for South San Francisco-based Harpoon, people in the know said.
-
Merck Is In Advanced Talks To Buy Cancer Drugmaker Harpoon Therapeutics
Merck is discussing paying roughly $23 a share for South San Francisco-based Harpoon, people in the know said.
-
Bill Gates Writes Book on How to Make Covid-19 the Last Pandemic
Bill Gates is planning a May 3 release for a book on how to ensure that the Covid-19 pandemic is the last great global plague.
-
Where Is the Operation Warp Speed for Covid Testing?
Where Is the Operation Warp Speed for Covid Testing?
-
Why America May Not Be Ready for the Next Pandemic
Why America May Not Be Ready for the Next Pandemic
-
Abortion Pill by Mail Now Allowed in U.S. Permanently, FDA Rules
Abortion Pill by Mail Now Allowed in U.S. Permanently, FDA Rules
-
Omicron Undetected in U.S. So Far, Testing Biden Sequencing Plan
Omicron Tests Biden’s $1.7 Billion Plan to Better Track Variants
-
Merck’s Covid Pill Changes Drugmaker’s Fate After Failed Shots
Merck’s drug molnupiravir reduced the risk of hospitalization or death by 50% in a late-stage clinical trial.
-
More Variants Are Coming, and the U.S. Isn’t Ready to Track Them
More Variants Are Coming, and the U.S. Isn’t Ready to Track Them
-
Merck Setback Limits Study of Covid Pill to Milder Disease
The pill reduced virus levels in patients but didn’t show a meaningful benefit in preventing hospitalizations and deaths.
-
Merck’s Little Brown Pill Could Transform the Fight Against Covid
Merck hopes the pills can be prescribed widely to anyone who gets sick. Think Tamiflu for Covid.
-
Inside Pfizer’s Fast, Fraught, and Lucrative Vaccine Distribution
Inside Pfizer’s Fast, Fraught, and Lucrative Vaccine Distribution
-
Talkspace Strikes $1.4 Billion Merger With Hudson Executive
Talkspace Agrees to $1.4 Billion Merger With Hudson Executive
-
Talkspace Working With Advisers on Possible Sale
Talkspace Working With Advisers on Possible Sale
-
Inside Operation Warp Speed’s $18 Billion Sprint for a Vaccine
Inside Operation Warp Speed’s $18 Billion Sprint for a Vaccine
